EFFECTS OF ANGIOTENSIN II RECEPTOR BLOCKADE IN SYSTEMIC SCLEROSIS: RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Abou-Raya, A. [1 ,2 ]
Abou-Raya, S. [1 ,2 ]
Helmii, M. [3 ]
机构：
[1] Univ Alexandria, Fac Med, Alexandria, Egypt
[2] Alexandria Ctr Womens Hlth, Alexandria, Egypt
[3] Med Res Inst, Alexandria, Egypt
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] Effect of Angiotensin II Type I Receptor Blockade on Carotid Artery Atherosclerosis: A Randomized Trial Comparing Valsartan and Placebo (EFFERVESCENT)
    Ramadan, Ronnie
    Khoder, Ayman
    Dhawan, Saurabh
    Binongo, Jose N.
    Ghafoor, Asad
    Syed, Hamid
    Ali, Muhammad
    Kitchen, Charles B.
    Sher, Salman
    Jones, Dean
    Oshinski, John
    Quyyumi, Arshed Ali
    CIRCULATION, 2013, 128 (24) : 2717 - 2717
  • [32] Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial
    Grassegger, A
    Schuler, G
    Hessenberger, G
    Walder-Hantich, B
    Jabkowski, J
    Macheiner, W
    Salmhofer, W
    Zahel, B
    Pinter, G
    Herold, M
    Klein, G
    Fritsch, PO
    BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (04) : 639 - 648
  • [33] Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial
    Romanazzo, Sara
    Ceccatelli, Sara
    Mansueto, Giovanni
    Sera, Francesco
    Guiducci, Serena
    Matucci Cerinic, Marco
    Cosci, Fiammetta
    RHEUMATOLOGY, 2024, 64 (02) : 667 - 674
  • [34] Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trial
    Argano, Christiano
    Scaglione, Rosario
    Di Chiara, Tiziana
    Colomba, Daniela
    Parrinello, Gaspare
    Corrao, Salvatore
    Licata, Giuseppe
    HEART INTERNATIONAL, 2006, 2 (01): : 39 - 48
  • [35] A NOVEL ANIMAL MODEL FOR SYSTEMIC SCLEROSIS INDUCED BY IMMUNISATION OF ANGIOTENSIN II RECEPTOR 1
    Yue, X.
    Petersen, F.
    Wang, X.
    Heidecke, H.
    Riemekasten, G.
    Yu, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 735 - 735
  • [36] Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study)
    Peters, Christian D.
    Kjaergaard, Krista D.
    Nielsen, Claus H.
    Christensen, Kent L.
    Bibby, Bo M.
    Jensen, Jens D.
    Jespersen, Bente
    HEMODIALYSIS INTERNATIONAL, 2017, 21 (01) : 47 - 62
  • [37] Interactive effects of vasopressin and angiotensin II receptor blockade with developing heart failure
    Clair, MJ
    King, MK
    Goldberg, AT
    Hendrick, JW
    Nisato, R
    McElmurray, JH
    Krombach, RS
    Jolly, JR
    Nisato, D
    Spinale, FG
    CIRCULATION, 2000, 102 (18) : 536 - 536
  • [38] Genetic contribution to the acute effects of angiotensin II type 1 receptor blockade
    Spiering, W
    Kroon, AA
    Lejeune, MJMJF
    de Leeuw, PW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 617 - 617
  • [39] Effects of angiotensin II type 1 receptor blockade on β-cell function in humans
    Bokhari, Syed
    Israelian, Zarmen
    Schmidt, Jonelle
    Brinton, Eliot
    Meyer, Christian
    DIABETES CARE, 2007, 30 (01) : 181 - 181
  • [40] Angiotensin II AT1 receptor blockade ameliorates the response of brain to the systemic immune challenge
    Benicky, Julius
    Sanchez-Lemus, Enrique
    Honda, Masaru
    Wang, Juan
    Orecna, Martina
    Saavedra, Juan M.
    FASEB JOURNAL, 2011, 25
12345